Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry

Single agents have demonstrated activity in relapsed and refractory (R/R) peripheral T-cell lymphoma (PTCL). Their benefit relative to combination chemotherapy remains undefined. Patients with histologically confirmed PTCL were enrolled in the Comprehensive Oncology Measures for Peripheral T-cell Ly...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Hematol
Päätekijät: Stuver, Robert N., Khan, Niloufer, Schwartz, Marc, Acosta, Mark, Federico, Massimo, Gisselbrecht, Christian, Horwitz, Steven M., Lansigan, Frederik, Pinter-Brown, Lauren C., Pro, Barbara, Shustov, Andrei R., Foss, Francine M., Jain, Salvia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928240/
https://ncbi.nlm.nih.gov/pubmed/30896890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25463
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia